fulvestrant
Generic: fulvestrant
Labeler: avenacy, inc.Drug Facts
Product Profile
Brand Name
fulvestrant
Generic Name
fulvestrant
Labeler
avenacy, inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
fulvestrant 50 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
83634-203
Product ID
83634-203_6ecfd7da-f2b6-453d-8105-5f6e0bf5e95f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA211422
Listing Expiration
2026-12-31
Marketing Start
2024-02-28
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
83634203
Hyphenated Format
83634-203
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
fulvestrant (source: ndc)
Generic Name
fulvestrant (source: ndc)
Application Number
ANDA211422 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/mL
Packaging
- 2 SYRINGE, GLASS in 1 CARTON (83634-203-74) / 5 mL in 1 SYRINGE, GLASS (83634-203-41)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR"], "spl_id": "6ecfd7da-f2b6-453d-8105-5f6e0bf5e95f", "openfda": {"nui": ["N0000175582", "N0000000145", "N0000000168"], "unii": ["22X328QOC4"], "rxcui": ["727762"], "spl_set_id": ["f44cffcc-8f5e-4a4c-a36e-ab946ce86266"], "pharm_class_epc": ["Estrogen Receptor Antagonist [EPC]"], "pharm_class_moa": ["Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "manufacturer_name": ["Avenacy, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, GLASS in 1 CARTON (83634-203-74) / 5 mL in 1 SYRINGE, GLASS (83634-203-41)", "package_ndc": "83634-203-74", "marketing_start_date": "20240228"}], "brand_name": "Fulvestrant", "product_id": "83634-203_6ecfd7da-f2b6-453d-8105-5f6e0bf5e95f", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Estrogen Receptor Antagonist [EPC]", "Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "product_ndc": "83634-203", "generic_name": "fulvestrant", "labeler_name": "Avenacy, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fulvestrant", "active_ingredients": [{"name": "FULVESTRANT", "strength": "50 mg/mL"}], "application_number": "ANDA211422", "marketing_category": "ANDA", "marketing_start_date": "20240228", "listing_expiration_date": "20261231"}